{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T19:55:57Z","timestamp":1776801357570,"version":"3.51.2"},"reference-count":23,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"unspecified","delay-in-days":68,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Trans. Sci."],"published-print":{"date-parts":[[2023]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:sec id=\"S2059866123000353_as1\">\n\t    <jats:title>Background:<\/jats:title>\n\t    <jats:p>Hyperbilirubinemia is common in the neonatal period; however, delayed diagnosis or inadequate treatment can cause irreparable damage to the neonates. We aimed to evaluate the efficacy of oral fenofibrate for hyperbilirubinemia in term neonates.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S2059866123000353_as2\">\n\t    <jats:title>Methods:<\/jats:title>\n\t    <jats:p>This single-blind randomized controlled trial included 86 term neonates aged 3\u20137 days, with birth weight \u22652500 g, admitted to Bandar Abbas Children\u2019s Hospital, Bandar Abbas Iran, from July 23, 2019, to July 22, 2020. The fenofibrate group received 10 mg\/kg oral fenofibrate and phototherapy, while controls only received phototherapy. Serum total bilirubin was measured at 24 and 48 h and at the time of discharge. Hospital length of stay was also noted.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S2059866123000353_as3\">\n\t    <jats:title>Results:<\/jats:title>\n\t    <jats:p>The two study groups were comparable regarding age, gender, gestational age, birth weight, and baseline total serum bilirubin levels. Serum total bilirubin levels at 48 h (<jats:italic>P<\/jats:italic> &lt; 0.001) and at discharge (<jats:italic>P<\/jats:italic> &lt; 0.001) were significantly lower in the fenofibrate group compared to controls. Although hospital length of stay was lower in the fenofibrate group compared to controls, the difference was not statistically significant (<jats:italic>P<\/jats:italic> = 0.612). Fenofibrate was more effective on the reduction of serum bilirubin in neonates aged 3\u20134.5 days starting at the 24<jats:sup>th<\/jats:sup> hour. Moreover, it was more effective in female neonates compared to males starting at the 48<jats:sup>th<\/jats:sup> hour.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S2059866123000353_as4\">\n\t    <jats:title>Conclusions:<\/jats:title>\n\t    <jats:p>A single dose of oral fenofibrate reduced total serum bilirubin in term neonates with hyperbilirubinemia without any side effects; however, this effect was more prominent after 48 h.<\/jats:p>\n\t  <\/jats:sec>","DOI":"10.1017\/cts.2023.35","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T08:38:49Z","timestamp":1678437529000},"source":"Crossref","is-referenced-by-count":8,"title":["Oral fenofibrate for hyperbilirubinemia in term neonates: A single-blind randomized controlled trial"],"prefix":"10.1017","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6228-4438","authenticated-orcid":false,"given":"Seyed Hossein","family":"Saadat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakhshaneh","family":"Goodarzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0763-9283","authenticated-orcid":false,"given":"Babak","family":"Gharaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"S2059866123000353_ref15","doi-asserted-by":"publisher","DOI":"10.33545\/26643685.2020.v3.i2b.97"},{"key":"S2059866123000353_ref16","first-page":"76","article-title":"Effect of fenofibrate on neonatal hyperbilirubinemia: A systematic review and meta-analysis","volume":"11","author":"Zamiri-Miandoab","year":"2020","journal-title":"Iranian Journal of Neonatology"},{"key":"S2059866123000353_ref12","first-page":"5","article-title":"Fenofibrate: A novel approach in treating uncomplicated neonatal hyperbilirubinemia","volume":"5","author":"Kumar","year":"2012","journal-title":"People\u2019s Journal of Scientific Research"},{"key":"S2059866123000353_ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201900128"},{"key":"S2059866123000353_ref6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.114.1.297"},{"key":"S2059866123000353_ref11","doi-asserted-by":"publisher","DOI":"10.1586\/14779072.6.10.1319"},{"key":"S2059866123000353_ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-020-00861-2"},{"key":"S2059866123000353_ref1","volume-title":"Nelson Textbook of Pediatrics","author":"Geme","year":"2020"},{"key":"S2059866123000353_ref4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-0253"},{"key":"S2059866123000353_ref7","doi-asserted-by":"publisher","DOI":"10.1089\/bfm.2015.0170"},{"key":"S2059866123000353_ref22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/2249-4847.154111","article-title":"Effect of fenofibrate on indirect neonatal hyperbilirubinemia","volume":"4","author":"Al-Asy","year":"2015","journal-title":"Journal of Clinical Neonatology"},{"key":"S2059866123000353_ref10","doi-asserted-by":"publisher","DOI":"10.32677\/IJCH.2016.v03.i01.012"},{"key":"S2059866123000353_ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6975.298"},{"key":"S2059866123000353_ref18","doi-asserted-by":"publisher","DOI":"10.9734\/ajpr\/2020\/v4i230147"},{"key":"S2059866123000353_ref20","first-page":"6","article-title":"Efficacy of oral fenofibrate in the management of unconjugated hyperbilirubinemia in neonates-A prospective study","volume":"10","author":"Anantha Narayana Gowda","year":"2020","journal-title":"International Journal of Recent Trends in Science and Technology"},{"key":"S2059866123000353_ref2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-1471"},{"key":"S2059866123000353_ref21","first-page":"8317","article-title":"The effect of oral fenofibrate on serum bilirubin level in term neonates with hyperbilirubinemia: a randomized clinical trail","volume":"6","author":"Ahmadpour-kacho","year":"2018","journal-title":"International Journal of Pediatrics"},{"key":"S2059866123000353_ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-7-44"},{"key":"S2059866123000353_ref5","doi-asserted-by":"publisher","DOI":"10.1111\/apa.14141"},{"key":"S2059866123000353_ref23","doi-asserted-by":"publisher","DOI":"10.21608\/anj.2020.69366"},{"key":"S2059866123000353_ref13","doi-asserted-by":"publisher","DOI":"10.21474\/IJAR01\/2676"},{"key":"S2059866123000353_ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197113"},{"key":"S2059866123000353_ref17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.31741\/ijhrmlp.v6.i1.2020.13","article-title":"Efficacy of oral fenofibrate in management of unconjugated hyperbilirubinemia in the neonate","volume":"6","author":"Pathak","year":"2020","journal-title":"International Journal of Health Research and Medico Legal Practice"}],"container-title":["Journal of Clinical and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2059866123000353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T08:16:12Z","timestamp":1680596172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2059866123000353\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023]]}},"alternative-id":["S2059866123000353"],"URL":"https:\/\/doi.org\/10.1017\/cts.2023.35","relation":{},"ISSN":["2059-8661"],"issn-type":[{"value":"2059-8661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"e85"}}